anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
MindMed · pitchdeck

MindMed | Investor Presentation Deck | 36 slides

36 pages · 5 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

MindMed | Investor Presentation Deck | 36 slides

MindMed · 2023-06
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 9 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Solution 5 slides 100% 5/5 slides 100% 5/5 slides · 23 hits
— 0/5 slides
100% 5/5 slides 60% 3/5 slides 100% 5/5 slides 100% 5/5 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Competition 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Financials 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides

Slide inventory

36
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
summarize
Open slide detail
04
The slide uses a grid layout to associate each executive with their past/current professional affiliations.other
Open slide detail
05
The slide highlights the depth of experience by listing previous company affiliations for each leader.other
Open slide detail
06
Uses a pictogram (4/5 dark blue) to visually represent the '1 in 5' statistic.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
07
The slide uses a matrix structure to categorize drug development strategy by generation (Classic, 2nd Gen/Optimized, 3rd Gen/NCEs).present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
08
The slide uses a Gantt-style chart to show the progress of different drug candidates through clinical development stages.plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
09
The slide uses a flywheel diagram to represent the R&D strategy and a bar chart to demonstrate the impact of IP strategies on market protection duration.present_framework
Open slide detailBeat · SolutionLoop · Golden Circle
10
plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
11
Uses a brain diagram to map specific therapeutic areas to clinical evidence points.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
12
Uses a brain scan visualization to illustrate the impact of a serotonin agonist.present_solution
Open slide detailBeat · Market Size
13
The slide uses a table to establish historical credibility for the company's therapeutic approach.establish_context
Open slide detail
14
Data source: Holze, Gasser et al. 2022. Biological Psychiatry.show_traction
Open slide detail
15
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.plan_implementation
Open slide detail
16
plan_implementation
Open slide detail
17
The slide uses a timeline diagram to illustrate the study flow from randomization to follow-up.plan_implementation
Open slide detail
18
The slide uses a process-oriented layout to describe the commercialization strategy.plan_implementation
Open slide detail
19
plan_implementation
Open slide detailLoop · Why Now
20
The slide uses a bar chart to bridge the gap between patient needs and the proposed solution's potential impact.frame_problem
Open slide detailBeat · Competition
21
The chart demonstrates the therapeutic index advantage of the R-enantiomer.present_solution
Open slide detail
22
The chart shows a comparison between Placebo and MDMA at 1 month and 6 months, indicating sustained improvement.show_traction
Open slide detail
23
transition
Open slide detail
24
The slide uses a line chart metaphor to show patient stability over time, highlighting the 'gap' filled by MM-110.present_solution
Open slide detail
25
The slide uses two distinct chart types (bar and line) to show efficacy across different translational markers.show_traction
Open slide detail
26
The slide uses a clear, bulleted list to summarize clinical trial outcomes.summarize
Open slide detail
27
transition
Open slide detail
28
The slide uses a three-column layout to map partners/capabilities to specific R&D stages.present_solution
Open slide detail
29
The slide highlights a strategic partnership and lists specific research programs (LSD, MDMA, Mescaline, DMT) and their strategic benefits.illustrate_case
Open slide detail
30
transition
Open slide detail
31
The slide uses a timeline-based framework to map specific digital solutions to different stages of drug development.present_solution
Open slide detail
32
The slide uses a linear process flow mapped to specific digital product features.present_framework
Open slide detail
33
The central diagram is a hub-and-spoke model showing stakeholder alignment.present_solution
Open slide detail
34
The slide uses a matrix-like layout to show product status across development phases.plan_implementation
Open slide detailBeat · Financials
35
summarize
Open slide detail
36
This appears to be a closing slide or a section divider given the page number 36.front_matter
Open slide detail